ORGO [NASD]
Organogenesis Holdings Inc.
Index- P/E8.98 EPS (ttm)0.64 Insider Own0.80% Shs Outstand128.79M Perf Week4.76%
Market Cap727.53M Forward P/E12.43 EPS next Y0.46 Insider Trans-46.01% Shs Float63.06M Perf Month-11.04%
Income85.00M PEG3.73 EPS next Q0.09 Inst Own46.10% Short Float13.17% Perf Quarter-20.33%
Sales463.60M P/S1.57 EPS this Y358.80% Inst Trans4.22% Short Ratio7.33 Perf Half Y-45.05%
Book/sh1.89 P/B3.03 EPS next Y35.29% ROA21.20% Target Price14.00 Perf Year-65.60%
Cash/sh0.85 P/C6.74 EPS next 5Y2.41% ROE39.90% 52W Range5.30 - 19.75 Perf YTD-38.10%
Dividend- P/FCF22.88 EPS past 5Y96.00% ROI32.40% 52W High-71.04% Beta1.39
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin75.50% 52W Low7.92% ATR0.48
Employees950 Current Ratio2.80 Sales Q/Q-4.40% Oper. Margin12.80% RSI (14)41.56 Volatility7.12% 8.29%
OptionableYes Debt/Eq0.30 EPS Q/Q-99.10% Profit Margin18.30% Rel Volume0.90 Prev Close5.64
ShortableYes LT Debt/Eq0.29 EarningsMay 10 AMC Payout0.00% Avg Volume1.13M Price5.72
Recom1.00 SMA20-7.00% SMA50-17.95% SMA200-42.38% Volume1,022,087 Change1.42%
Jan-10-20Initiated SVB Leerink Outperform $9
Aug-26-19Resumed Credit Suisse Outperform $9 → $10
May-02-19Initiated Credit Suisse Outperform $9
Apr-17-19Initiated Oppenheimer Outperform $11
Apr-11-19Initiated SunTrust Buy $11
May-11-22 05:00AM  
May-10-22 05:35PM  
04:05PM  
06:05AM  
May-05-22 04:05PM  
May-02-22 11:08AM  
Apr-18-22 01:58PM  
Apr-05-22 04:30PM  
04:05PM  
Mar-17-22 09:00AM  
Mar-08-22 07:30AM  
Mar-04-22 06:46AM  
Mar-02-22 05:48PM  
Mar-01-22 10:00PM  
07:25PM  
04:05PM  
Feb-17-22 04:05PM  
Feb-16-22 08:54AM  
Feb-11-22 07:30AM  
Feb-07-22 07:30AM  
Feb-02-22 01:38PM  
Feb-01-22 09:38AM  
Jan-24-22 09:58AM  
Jan-20-22 01:00PM  
Dec-31-21 07:11PM  
02:49PM  
02:40PM  
01:00PM  
Dec-30-21 03:27PM  
03:15PM  
09:45AM  
Dec-29-21 11:35PM  
11:27PM  
04:23PM  
10:15AM  
Dec-28-21 05:55PM  
02:39PM  
11:45AM  
09:45AM  
Dec-27-21 03:22PM  
02:20PM  
01:45PM  
12:00PM  
11:00AM  
Dec-26-21 10:40PM  
Dec-25-21 08:10PM  
Dec-24-21 03:20PM  
01:49PM  
10:40AM  
Dec-23-21 09:56PM  
05:10PM  
09:30AM  
Dec-22-21 05:00PM  
04:36PM  
02:32PM  
11:00AM  
09:40AM  
Dec-21-21 08:07PM  
07:20PM  
07:18PM  
04:06PM  
11:00AM  
09:20AM  
06:02AM  
Dec-20-21 08:52PM  
03:44PM  
11:00AM  
10:35AM  
10:30AM  
10:15AM  
10:00AM  
09:30AM  
Dec-19-21 09:00PM  
06:34PM  
Dec-18-21 12:20PM  
09:55AM  
Dec-17-21 05:11PM  
05:02PM  
04:30PM  
01:00PM  
12:30PM  
11:20AM  
11:00AM  
09:35AM  
Dec-16-21 10:53PM  
04:15PM  
04:00PM  
03:08PM  
12:00PM  
11:00AM  
09:55AM  
09:40AM  
09:30AM  
08:50AM  
Dec-15-21 05:00PM  
04:04PM  
03:37PM  
02:30PM  
12:38PM  
12:00PM  
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved. Its surgical and sports medicine products comprise NuCel, a dehydrated placental tissue surgically applied to the target tissue to support native healing; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gillheeney Gary S.President and CEOMay 25Option Exercise0.9984,67483,827482,916May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 25Sale5.6084,674474,174398,242May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 24Option Exercise0.9952,31251,789450,554May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 24Sale5.6652,312296,086398,242May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 23Option Exercise0.9960,35059,746458,592May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 23Sale5.8060,350350,297398,242May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 20Option Exercise0.9958,65458,067456,896May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 20Sale5.8958,654345,472398,242May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 19Option Exercise0.99118,504117,319516,746May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 19Sale5.94118,504703,914398,242May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 18Option Exercise0.9986,53185,666484,773May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 18Sale5.4686,531472,459398,242May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 17Option Exercise0.9998,07897,097496,320May 17 08:11 PM
Gillheeney Gary S.President and CEOMay 17Sale5.9098,078578,660398,242May 17 08:11 PM
Gillheeney Gary S.President and CEOMay 16Option Exercise0.9980,36979,565478,611May 17 08:11 PM
KATZ MICHAEL W10% OwnerMay 16Buy6.0310,00060,29870,382May 18 05:04 PM
Gillheeney Gary S.President and CEOMay 16Sale5.9280,369475,784398,242May 17 08:11 PM
Gillheeney Gary S.President and CEOMay 13Option Exercise0.99136,390135,026534,632May 17 08:11 PM
Gillheeney Gary S.President and CEOMay 13Sale6.17136,390841,113398,242May 17 08:11 PM
Montecalvo Antonio S.Vice President, Health PolicyMar 10Option Exercise3.4668,504237,024141,725Mar 11 06:42 PM
Montecalvo Antonio S.Vice President, Health PolicyMar 10Sale8.3997,436817,48844,289Mar 11 06:42 PM
Montecalvo Antonio S.Vice President, Health PolicyMar 09Sale8.5210,00085,20073,221Mar 11 06:42 PM
KATZ MICHAEL W10% OwnerDec 13Buy9.655004,82560,382Dec 14 06:47 PM
KATZ MICHAEL W10% OwnerDec 03Buy9.358007,48059,882Dec 06 05:48 PM
KATZ MICHAEL W10% OwnerDec 02Buy9.661,80017,39059,082Dec 06 05:48 PM
KATZ MICHAEL W10% OwnerNov 29Buy9.751,0009,75057,282Dec 01 06:17 PM
KATZ MICHAEL W10% OwnerNov 26Buy9.792,00019,57056,282Nov 30 08:15 PM
GN 2016 Organo 10-Year GRAT u/10% OwnerNov 18Buy9.9325,000248,25059,448,027Nov 22 08:39 PM
NUSSDORF GLENN HDirectorNov 18Buy9.9325,000248,25059,448,027Nov 22 08:39 PM
KATZ MICHAEL W10% OwnerNov 17Buy10.871,00010,87054,282Nov 19 05:03 PM
KATZ MICHAEL W10% OwnerNov 15Buy11.081,00011,08053,282Nov 19 05:03 PM
KATZ MICHAEL W10% OwnerNov 12Buy11.203,00033,60052,282Nov 19 05:03 PM
Bilbo PatrickChief Operating OfficerNov 10Option Exercise1.4430,45043,848133,670Nov 12 06:01 PM
KATZ MICHAEL W10% OwnerAug 17Buy13.5512,000162,60049,282Aug 19 07:38 PM
Gillheeney Gary S.President and CEOJul 19Option Exercise0.99160,237158,635292,154Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 19Sale14.02160,2372,246,523131,917Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 16Option Exercise3.51139,763490,488271,680Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 16Sale14.74139,7632,059,820131,917Jul 20 08:45 PM
ERANI ALBERT10% OwnerJun 09Sale15.31150,0002,296,50059,432,133Jun 10 09:33 PM
Albert Erani Family Trust date10% OwnerJun 09Sale15.31150,0002,296,50059,432,133Jun 10 09:27 PM
ERANI ALBERT10% OwnerJun 08Sale15.41100,0001,541,00059,582,133Jun 08 08:03 PM
Albert Erani Family Trust date10% OwnerJun 08Sale15.41100,0001,541,00059,582,133Jun 08 07:52 PM
Albert Erani Family Trust date10% OwnerJun 07Sale16.1494,6121,527,03859,682,133Jun 08 07:52 PM
ERANI ALBERT10% OwnerJun 07Sale16.1494,6121,527,03859,682,133Jun 08 08:03 PM
ERANI ALBERT10% OwnerJun 04Sale16.2260,000973,20059,776,745Jun 08 08:03 PM
Albert Erani Family Trust date10% OwnerJun 04Sale16.2260,000973,20059,776,745Jun 08 07:52 PM
Erani Dennis10% OwnerMay 27Sale18.979,106172,7411,314,517Jun 28 09:17 PM
NUSSDORF GLENN HDirectorMay 27Sale16.403,887,50063,755,00059,836,745May 28 09:37 PM
Ades Alan A.DirectorMay 27Sale16.403,887,50063,755,00059,836,745May 28 09:32 PM